TNX-102 SL for Major Depressive Disorder
Part of Mental health clinical trials.
This study tests whether a new medication called TNX-102 SL can reduce depression symptoms better than a placebo (inactive pill). You'll take the medication daily and have regular check-ins to see how you're doing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have major depressive disorder (clinical depression) as your primary diagnosis
- Your current depressive episode has lasted between 6 weeks and 18 months
- You do not have psychotic features (such as hallucinations or delusions) or catatonic features (extreme lack of movement or response)
- You have not failed 2 or more adequate trials of different antidepressant medications in the past
- You have not used alcohol or other substances as a primary problem in the past 12 months
- You are willing to stop most antidepressants for 4–6 weeks before starting the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new medication, DT-101, can help when added to your current depression treatment. It's for adults with recurrent depression who may need extra support.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This trial tests a new medicine called DT-101 to see if it helps people with depression. It is for adults who have had more than one depressive episode in their life.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This study tests a new antidepressant tablet against an approved one to see which works better and is safer for adults with major depression. It may help find a more effective option for treating depressive symptoms.
This study tests a new medication called BMS-986511 for adults with major depressive disorder. It aims to see if the drug can help relieve depression symptoms more effectively than a placebo.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.